US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Telomir Pharmaceuticals

2.15

+0.14006.97%

Volume:182.16K

Turnover:380.32K

Market Cap:63.99M

PE:-5.18

High:2.15

Open:2.07

Low:2.01

Close:2.01

Loading ...

Overview Company News Filings

Telomir Pharmaceuticals Says Telomir-1 Compound Stabilizes Silver for Advanced Medical Applications

MT Newswires Live

Telomir says captured, stabilized silver in biologically compatible form

Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market

ACCESS Newswire

TELO Announces Breakthrough

Zacks Small Cap Research

Telomir Pharmaceuticals, Inc. (TELO) Receives a New Rating from Rodman & Renshaw

Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)

ACCESS Newswire

Telomir Pharmaceuticals: Telomir-1 Treatment Resulted in a Significant Reduction of Ros Elevation

THOMSON REUTERS

TELO Again Announces Breakthrough Results

Zacks Small Cap Research

Telomir Pharmaceuticals files $150M mixed securities shelf

Telomir Pharmaceuticals Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing

THOMSON REUTERS

TELO Improves Balance Sheet

Zacks Small Cap Research

Telomir Pharmaceuticals announces results from preclinical studies of Telomir-1

Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses

ACCESS Newswire

BRIEF-Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1

Telomir Pharmaceuticals Inc - Telomir-1 Reverses Copper-Induced Ros Elevation in Human Cell Lines

THOMSON REUTERS

TELO Treatment Amazes in Preclinical Trial

Zacks Small Cap Research

Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) market cap surged US$16m last week, retail investors who have a lot riding on the company were rewarded

Simply Wall St.

Zacks Small Cap Research 2024 Initiations and Best Ideas for 2025

Zacks Small Cap Research

Renovaro Names Nathen Fuentes as CFO

MT Newswires Live

Telomir announces findings from preclinical progeria lifespan study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TELO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TELO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TELO\",,,,,undefined,":{"symbol":"TELO","market":"US","secType":"STK","nameCN":"Telomir Pharmaceuticals","latestPrice":2.15,"timestamp":1749240000000,"preClose":2.01,"halted":0,"volume":182156,"delay":0,"floatShares":17618248,"shares":29762671,"eps":-0.414741,"marketStatus":"Pre-Mkt","change":0.14,"latestTime":"06-09 04:56:36 EDT","open":2.07,"high":2.15,"low":2.0065,"amount":380319.03136240004,"amplitude":0.071393,"askPrice":2.33,"askSize":100,"bidPrice":1.9,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.414741,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749475800000},"marketStatusCode":1,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":2.15,"postHourTrading":{"tag":"盘后","latestPrice":2.16,"preClose":2.15,"latestTime":"19:25 EDT","volume":278,"amount":590.687,"timestamp":1749252308896},"volumeRatio":0.4108868457844474},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TELO\",,,,,undefined,":{"symbol":"TELO","floatShares":17618248,"roa":"-391.62%","roe":"-872.57%","lyrEps":-0.559686,"volumeRatio":0.4108868457844474,"shares":29762671,"dividePrice":0,"high":2.15,"amplitude":0.071393,"preClose":2.01,"low":2.0065,"week52Low":1.87,"pbRate":"-397.19","week52High":8.4,"institutionHeld":0,"latestPrice":2.15,"eps":-0.414741,"divideRate":0,"volume":182156,"delay":0,"ttmEps":-0.414741,"open":2.07,"prevYearClose":4.12,"prevWeekClose":2.15,"prevMonthClose":1.945,"prevQuarterClose":3.23,"fiveDayClose":1.945,"twentyDayClose":2.52,"sixtyDayClose":4.94},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TELO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513474298","title":"Telomir Pharmaceuticals Says Telomir-1 Compound Stabilizes Silver for Advanced Medical Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2513474298","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513474298?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:55","pubTimestamp":1740146138,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals  said Friday it was able to stabilize both Silver and the highly reactive Silver in a biologically compatible form with its Telomir-1 compound.The company said the Telomir-1 compound would help overcome hurdles in silver-based medical applications and open up new possibilities for advanced antimicrobial treatments, wound care, and infection-resistant medical coatings.The silver-based medical treatments market is rapidly growing, with the silver wound dressings segment valued at $1.03 billion in 2024 and expected to reach $1.36 billion by 2030, the company said.Additionally, the company added that the antimicrobial coatings market, which includes silver-infused medical devices, hospital surfaces, and implants, is projected to grow from $11.65 billion in 2024 to $33.7 billion by 2031.Telomir said it is advancing research and development to explore clinical applications of stabilized Silver complexed-Telomir-1 and is evaluating regulatory pathways to bring these in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLZ.SI","BK6522","BK6088","COMP.USD.HKCC","COMP.USD.CC","IE00B66KJ199.SGD","TELO","IE0031619046.USD","AEIS","IE00B7SZL793.SGD","BK4007","BK4157","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2513393260","title":"Telomir says captured, stabilized silver in biologically compatible form","url":"https://stock-news.laohu8.com/highlight/detail?id=2513393260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513393260?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:15","pubTimestamp":1740143721,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals (TELO) announced Telomir-1 has captured and stabilized both Silver and the highly reactive Silver in a biologically compati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/telomir-says-captured-stabilized-silver-in-biologically-compatible-form?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/telomir-says-captured-stabilized-silver-in-biologically-compatible-form?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2513606712","title":"Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2513606712","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513606712?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:00","pubTimestamp":1740142800,"startTime":"0","endTime":"0","summary":"MIAMI, FLORIDA / ACCESS Newswire / February 21, 2025 / Telomir Pharmaceuticals, Inc. , or Telomir, a leader in age-reversal science, today announced a breakthrough achievement-Telomir-1 has successfully captured and stabilized both Silver  and the highly reactive Silver  in a biologically compatible form. This milestone overcomes a major limitation in silver-based medical applications, opening the door for advanced antimicrobial treatments, wound care solutions, and infection-resistant medical coatings.Silver-based medical treatments represent a rapidly growing market, with the silver wound dressings segment valued at $1.03 billion in 2024 and projected to reach $1.36 billion by 2030  . Additionally, the antimicrobial coatings market-which includes silver-infused medical devices, hospital surfaces, and implants-is expected to grow from $11.65 billion in 2024 to $33.7 billion by 2031, at a CAGR of 14.2%  .Anti-Inflammatory and Immune-Modulating Properties - Silver may reduce excessive i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telomir-pharmaceuticals-achieves-breakthrough-silver-130000887.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2513446291","title":"TELO Announces Breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2513446291","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513446291?lang=en_us&edition=fundamental","pubTime":"2025-02-21 18:08","pubTimestamp":1740132480,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals  is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. In fact, the company recently released results from one of those tests, which, according to CEO Erez Aminov, “confirms Telomir-1 can reverse biologic aging, extending life while preserving health.”The ability to harness the abilities of Silver has an enormous potential impact, including:. Increased Oxidizing Power – Ag is a stronger oxidizing agent than Ag, which could make it more effective at disrupting bacterial cell membranes, proteins, and DNA, potentially leading to enhanced antimicrobial activity.While at the beginning stages of discovery, this development has a large economic potential, with the antimicrobial coatings market expected to grow t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telo-announces-breakthrough-100800310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2513529082","title":"Telomir Pharmaceuticals, Inc. (TELO) Receives a New Rating from Rodman & Renshaw","url":"https://stock-news.laohu8.com/highlight/detail?id=2513529082","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513529082?lang=en_us&edition=fundamental","pubTime":"2025-02-21 17:15","pubTimestamp":1740129319,"startTime":"0","endTime":"0","summary":"Rodman & Renshaw analyst Elemer Piros initiated coverage with a Buy rating on Telomir Pharmaceuticals, Inc. (TELO – Research Report) yesterday and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/telomir-pharmaceuticals-inc-telo-receives-a-new-rating-from-rodman-renshaw?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/telomir-pharmaceuticals-inc-telo-receives-a-new-rating-from-rodman-renshaw?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELO"],"gpt_icon":0},{"id":"2512157329","title":"Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2512157329","media":"ACCESS Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512157329?lang=en_us&edition=fundamental","pubTime":"2025-02-18 21:00","pubTimestamp":1739883600,"startTime":"0","endTime":"0","summary":"MIAMI, FLORIDA / ACCESS Newswire / February 18, 2025 / Telomir Pharmaceuticals, Inc. , or Telomir, a leader in age-reversal science, today announced groundbreaking results from its recent preclinical studies conducted in human retinal cell lines. These studies demonstrated the ability of Telomir-1 to significantly reverse copper and iron-induced elevation of Reactive Oxygen Species .AMD is a leading cause of blindness in adults over 50, affecting millions worldwide. The disease is characterized by the progressive deterioration of the retinal pigment epithelium  and photoreceptor cells, leading to central vision loss. AMD is classified into two forms:. Dry  AMD, the most common form, which is characterized by a gradual loss of RPE and photoreceptors due to oxidative stress and inflammation.Telomir's lead compound, Telomir-1, was developed to neutralize metal-induced oxidative stress-a key driver of AMD progression. In a recently conducted preclinical study using human retinal cell lines","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telomir-pharmaceuticals-announces-significant-reduction-130000158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMD","LU1064131342.USD","BK4529","LU0823434740.USD","LU2250418816.HKD","LU0081259029.USD","LU1803068979.SGD","LU0056508442.USD","LU0719512351.SGD","GFS","LU1242518857.USD","IE0009356076.USD","IE00BMPRXR70.SGD","LU2458330169.SGD","LU0889565833.HKD","LU0198837287.USD","LU0979878070.USD","LU1880398554.USD","BK4007","BK4534","LU2098885051.SGD","IE00BMPRXN33.USD","LU0082616367.USD","LU0390134368.USD","BK4141","LU1989764664.SGD","BK4566","LU1951200564.SGD","LU0823421333.USD","IE00B5949003.HKD","BK4532","BK4543","BK4605","LU0127658192.USD","LU1242518931.SGD","TELO","LU1951198990.SGD","LU1923623000.USD","LU2054465674.USD","BK4512","LU1316542783.SGD","LU2264538146.SGD","BK4554","LU1880398471.USD","LU0823421416.USD","LU2458330243.SGD","LU2360106780.USD","BK4575","IE0004445239.USD","BK4588"],"gpt_icon":1},{"id":"2512151494","title":"Telomir Pharmaceuticals: Telomir-1 Treatment Resulted in a Significant Reduction of Ros Elevation","url":"https://stock-news.laohu8.com/highlight/detail?id=2512151494","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512151494?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:34","pubTimestamp":1739882093,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P90KX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2512164443","title":"TELO Again Announces Breakthrough Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2512164443","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512164443?lang=en_us&edition=fundamental","pubTime":"2025-02-18 18:45","pubTimestamp":1739875500,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals  is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. In fact, the company recently released results from one of those tests, which, according to CEO Erez Aminov, “confirms Telomir-1 can reverse biologic aging, extending life while preserving health.”The company also recently released potential groundbreaking results from a preclinical study of Telomir-1 on human retinal cell lines. Data from the test showed the ability of Telomir-1 to “significantly reverse copper- and iron-induced elevation of Reactive Oxygen Species .”According to the company, there are currently no approved drugs specifically targeting the oxidative stress caused by the bird flu or similar viruses. Telomir-1’s ability to reverse oxid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telo-again-announces-breakthrough-results-104500500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1880398554.USD","LU1880398471.USD","LU1923623000.USD","BK4534","IE00B5949003.HKD","LU2098885051.SGD","BK4141","LU1242518931.SGD","IE0004445239.USD","IE00BMPRXN33.USD","LU0109392836.USD","LU0390134368.USD","LU2360106780.USD","BK4529","LU0823421416.USD","LU2458330243.SGD","LU0823434583.USD","BK4585","LU0823421333.USD","LU0198837287.USD","LU1988902786.USD","IE0009356076.USD","IE00BMPRXR70.SGD","LU1064131342.USD","LU1303367103.USD","BK4575","BK4605","LU2458330169.SGD","BK4573","TELO","LU1242518857.USD","LU0056508442.USD","LU0979878070.USD","BK4007","LU0823434740.USD","BK4532","LU1951198990.SGD","LU0082616367.USD","LU1852331112.SGD","LU0127658192.USD","BK4543","LU2250418816.HKD","LU0642271901.SGD","LU1316542783.SGD","LU0719512351.SGD","LU1951200564.SGD","LU0889565833.HKD","LU2054465674.USD","BK4588"],"gpt_icon":1},{"id":"2511643307","title":"Telomir Pharmaceuticals files $150M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2511643307","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511643307?lang=en_us&edition=fundamental","pubTime":"2025-02-15 06:05","pubTimestamp":1739570717,"startTime":"0","endTime":"0","summary":"17:02 EST Telomir Pharmaceuticals (TELO) files $150M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/telomir-pharmaceuticals-files-150m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/telomir-pharmaceuticals-files-150m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2511648925","title":"Telomir Pharmaceuticals Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2511648925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511648925?lang=en_us&edition=fundamental","pubTime":"2025-02-15 06:01","pubTimestamp":1739570518,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nFWN3P528V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2509341492","title":"TELO Improves Balance Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2509341492","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509341492?lang=en_us&edition=fundamental","pubTime":"2025-02-05 20:27","pubTimestamp":1738758420,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals  is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. In fact, the company recently released results from one of those tests, which, according to CEO Erez Aminov, “confirms Telomir-1 can reverse biologic aging, extending life while preserving health.”Company management just released its 2024 annual report that showed the company’s progress in advancing their research, while also showing an improvement in the cash balance from the year ago period—a very positive development for a company at this stage.The company also recently released potential groundbreaking results from a preclinical study of Telomir-1 on human cell lines. Data from the test showed the ability of Telomir-1 to “fully reverse copper-indu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telo-improves-balance-sheet-122700951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2506515281","title":"Telomir Pharmaceuticals announces results from preclinical studies of Telomir-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2506515281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506515281?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:30","pubTimestamp":1738071029,"startTime":"0","endTime":"0","summary":"Telomir announced results from its recent preclinical studies conducted in human cell lines. These studies demonstrated the ability of Telomir-1 to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/telomir-pharmaceuticals-announces-results-from-preclinical-studies-of-telomir-1?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/telomir-pharmaceuticals-announces-results-from-preclinical-studies-of-telomir-1?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2507543003","title":"Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses","url":"https://stock-news.laohu8.com/highlight/detail?id=2507543003","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507543003?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:00","pubTimestamp":1738069200,"startTime":"0","endTime":"0","summary":"Oxidative stress drives aging and is a key factor in diseases like Alzheimer's, Age-related Macular Degeneration , cardiovascular diseases, cancer, and diabetes. It also plays a critical role in the progression of viral infections, such as avian influenza , by exacerbating inflammation and cellular damage. Directly addressing oxidative stress and its consequences is essential to treating the underlying causes of these conditions and mitigating the severity of viral outbreaks.MIAMI, FLORIDA / ACCESS Newswire / January 28, 2025 / Telomir Pharmaceuticals, Inc. , or Telomir, a leader in age-reversal science, today announced groundbreaking results from its recent preclinical studies conducted in human cell lines. These studies demonstrated the ability of Telomir-1 to fully reverse copper-induced elevation of Reactive Oxygen Species  and provide robust cellular protection against copper toxicity.Erez Aminov, Chairman and CEO of Telomir, added, \"With its unique regulatory mechanism and broad ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telomir-pharmaceuticals-announces-breakthrough-results-130000525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1951198990.SGD","LU2360106780.USD","LU0823434583.USD","TELO","IE0009356076.USD","LU2250418816.HKD","BK4585","LU1316542783.SGD","LU0081259029.USD","AMD","IE0004445239.USD","IE00B5949003.HKD","IE00BMPRXN33.USD","BK4588","BK4566","GFS","LU0823421333.USD","BK4554","LU1852331112.SGD","LU2458330243.SGD","LU1803068979.SGD","LU2054465674.USD","LU0642271901.SGD","LU1951200564.SGD","LU2098885051.SGD","BK4141","LU2264538146.SGD","BK4512","LU1989764664.SGD","BK4534","LU0082616367.USD","BK4532","BK4543","BK4573","BK4529","LU0390134368.USD","LU0056508442.USD","LU0127658192.USD","LU1064131342.USD","LU1880398554.USD","LU1303367103.USD","BK4007","LU1923623000.USD","BK4575","LU0198837287.USD","LU1242518931.SGD","LU0823421416.USD","LU0109392836.USD","LU1988902786.USD","LU0979878070.USD"],"gpt_icon":1},{"id":"2506268590","title":"BRIEF-Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2506268590","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506268590?lang=en_us&edition=fundamental","pubTime":"2025-01-28 20:39","pubTimestamp":1738067958,"startTime":"0","endTime":"0","summary":"BRIEF-Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1Jan 28 (Reuters) - Telomir Pharmaceuticals Inc TELO.O:TELOMIR PHARMACEUTICALS INC - ANNOUNCES BREAKTHROUGH RESULTS WITH TELOM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nFWN3OO16I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2506426590","title":"Telomir Pharmaceuticals Inc - Telomir-1 Reverses Copper-Induced Ros Elevation in Human Cell Lines","url":"https://stock-news.laohu8.com/highlight/detail?id=2506426590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506426590?lang=en_us&edition=fundamental","pubTime":"2025-01-28 20:34","pubTimestamp":1738067678,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nFWN3OO16I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2507054583","title":"TELO Treatment Amazes in Preclinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2507054583","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507054583?lang=en_us&edition=fundamental","pubTime":"2025-01-28 19:06","pubTimestamp":1738062360,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals  is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. In fact, the company recently released results from one of those tests, which, according to CEO Erez Aminov, “confirms Telomir-1 can reverse biologic aging, extending life while preserving health.”The company just released potential groundbreaking results from a preclinical study of Telomir-1 on human cell lines. Data from the test showed the ability of Telomir-1 to “fully reverse copper-induced elevation of Reactive Oxygen Species  and provided robust cellular protection against copper toxicity.”This announcement adds to the list of conditions that Telomir-1 has the potential to treat by attacking the underlying causes of the conditions and not just ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telo-treatment-amazes-preclinical-trial-110600677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2503913073","title":"Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) market cap surged US$16m last week, retail investors who have a lot riding on the company were rewarded","url":"https://stock-news.laohu8.com/highlight/detail?id=2503913073","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503913073?lang=en_us&edition=fundamental","pubTime":"2025-01-16 19:25","pubTimestamp":1737026745,"startTime":"0","endTime":"0","summary":"Key Insights Significant control over Telomir Pharmaceuticals by retail investors implies that the general public has...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-telo/telomir-pharmaceuticals/news/telomir-pharmaceuticals-incs-nasdaqtelo-market-cap-surged-us","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["USAW.SI","TELO","TSYW.SI","TQQQ","BK4585","NVIW.SI","IE00B64PRP62.GBP","IE00BKPKM429.USD","USJW.SI","BK4588","QID","BK4112","LU2210149790.SGD","LU2095319765.USD","IE00BGHQF748.EUR","PSQ","LU2210150020.SGD","SQQQ","QLD","NDAQ",".IXIC","IE00B3QW5Z07.USD","NQmain","MNQmain","BK4007"],"gpt_icon":1},{"id":"2503581014","title":"Zacks Small Cap Research 2024 Initiations and Best Ideas for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503581014","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503581014?lang=en_us&edition=fundamental","pubTime":"2025-01-13 17:00","pubTimestamp":1736758800,"startTime":"0","endTime":"0","summary":"Zacks Small Cap Research was hard at work in 2024 initiating analyst coverage on 40 companies. Each of our initiation reports provides a valuation, investment thesis and financial forecast model that comes from our 11 experienced analysts’ expertise and due diligence. Our work has generated investment ideas in health care, consumer electronics, finance technologies, transportation, AI-based products, and oil and gas production among other industries.The last year has been one fraught with risks, critical elections around the globe and multiple ongoing military conflicts among other material events. Despite this, index performance as measured by the S&P was positive in 2024, with large caps outperforming mid-caps and mid-caps surpassing small caps. Much of the strong performance was driven by tech stocks and the Magnificent Seven while other areas lagged.Ligand Pharmaceuticals  is a royalty aggregator which has a large opportunity set of biopharma names where it can deploy its capital f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-small-cap-research-2024-090000334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USAW.SI","MNQmain","BK4166","TSYW.SI","BK4579","MTVA","SQQQ","TQQQ","TELO","BK4152","LU0566484027.USD","QID","USJW.SI","NVIW.SI",".IXIC","TWI","QLD","LU1559883803.SGD","BK4191","LGND","VIOT","NQmain","BK4007","BK4139","PSQ","CPSS"],"gpt_icon":1},{"id":"2501783819","title":"Renovaro Names Nathen Fuentes as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2501783819","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501783819?lang=en_us&edition=fundamental","pubTime":"2025-01-07 23:02","pubTimestamp":1736262170,"startTime":"0","endTime":"0","summary":"Renovaro  said Tuesday it has appointed Nathen Fuentes as chief financial officer, replacing interim CFO Simon Tarsh.Fuentes, whose appointment took effect Jan. 2, was previously CFO at Telomir Pharmaceuticals , Renovaro said.Renovaro shares rose 3% in recent Tuesday trading.Price: 1.03, Change: +0.03, Percent Change: +3.30","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RENB","BK4139","TELO","BK4007"],"gpt_icon":0},{"id":"2501204142","title":"Telomir announces findings from preclinical progeria lifespan study","url":"https://stock-news.laohu8.com/highlight/detail?id=2501204142","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501204142?lang=en_us&edition=fundamental","pubTime":"2025-01-07 21:52","pubTimestamp":1736257975,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals (TELO) announced findings from a preclinical progeria lifespan study conducted in collaboration with Nagi Bioscience SA. Ut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/telomir-announces-findings-from-preclinical-progeria-lifespan-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/telomir-announces-findings-from-preclinical-progeria-lifespan-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELO","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TELO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"TELO","fiscalQuarterEnding":"2025/03","expectedEps":-0.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2025-02-04","symbol":"TELO","fiscalQuarterEnding":"2024/12","expectedEps":-0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2024-11-12","symbol":"TELO","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TELO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TELO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TELO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TELO","date":"2025-06-06","current":-4.801996,"percent":0.930303,"low":-83.265127,"twenty":-11.15375,"median":-7.4411,"eighty":-5.738446,"high":-4.268373,"avg":-12.39152,"sd":14.41331,"marketCap":59822968},"quantilePoints":[{"date":"2024-02-16","current":-56.39638,"twenty":-61.770129,"median":-49.049457,"eighty":-41.982417,"marketCap":238655100},{"date":"2024-02-23","current":-62.343889,"twenty":-63.029602,"median":-60.594622,"eighty":-46.922348,"marketCap":263823442},{"date":"2024-03-01","current":-63.46342,"twenty":-63.421438,"median":-62.588787,"eighty":-53.457611,"marketCap":268561012},{"date":"2024-03-08","current":-60.874505,"twenty":-63.351467,"median":-62.553802,"eighty":-58.915325,"marketCap":257605381},{"date":"2024-03-15","current":-45.550923,"twenty":-63.197532,"median":-61.749139,"eighty":-48.657621,"marketCap":192759889},{"date":"2024-03-22","current":-47.510102,"twenty":-63.029602,"median":-60.594622,"eighty":-45.928765,"marketCap":201050637},{"date":"2024-03-28","current":-35.580099,"twenty":-62.973626,"median":-56.39638,"eighty":-42.472212,"marketCap":150565904},{"date":"2024-04-05","current":-16.558518,"twenty":-62.833684,"median":-48.559663,"eighty":-36.881554,"marketCap":216450701},{"date":"2024-04-12","current":-18.574281,"twenty":-62.595784,"median":-46.390571,"eighty":-17.881143,"marketCap":242800474},{"date":"2024-04-19","current":-18.007992,"twenty":-62.469837,"median":-45.480952,"eighty":-18.234508,"marketCap":235398021},{"date":"2024-04-26","current":-15.402836,"twenty":-62.287913,"median":-41.632564,"eighty":-16.272973,"marketCap":201343774},{"date":"2024-05-03","current":-15.493668,"twenty":-61.8401,"median":-38.868721,"eighty":-15.530047,"marketCap":202531127},{"date":"2024-05-10","current":-14.814122,"twenty":-61.126399,"median":-34.985348,"eighty":-15.280653,"marketCap":193648183},{"date":"2024-05-17","current":-9.713938,"twenty":-60.762552,"median":-20.205194,"eighty":-14.460757,"marketCap":183044909},{"date":"2024-05-24","current":-9.899514,"twenty":-60.034856,"median":-18.959358,"eighty":-13.282876,"marketCap":186541828},{"date":"2024-05-31","current":-9.506677,"twenty":-58.635442,"median":-18.087272,"eighty":-12.474215,"marketCap":179139374},{"date":"2024-06-07","current":-8.846709,"twenty":-55.220872,"median":-16.988785,"eighty":-10.175947,"marketCap":166703252},{"date":"2024-06-14","current":-8.642433,"twenty":-50.224965,"median":-16.082609,"eighty":-9.764378,"marketCap":162853977},{"date":"2024-06-21","current":-8.249595,"twenty":-49.049457,"median":-15.652229,"eighty":-9.506677,"marketCap":155451523},{"date":"2024-06-28","current":-7.558201,"twenty":-48.069868,"median":-15.505107,"eighty":-8.846709,"marketCap":142423205},{"date":"2024-07-05","current":-6.803952,"twenty":-47.622055,"median":-15.431264,"eighty":-8.793283,"marketCap":128210494},{"date":"2024-07-12","current":-6.489682,"twenty":-46.614477,"median":-14.995334,"eighty":-8.611006,"marketCap":122288531},{"date":"2024-07-19","current":-5.892568,"twenty":-46.222641,"median":-14.134574,"eighty":-8.227596,"marketCap":111036802},{"date":"2024-07-26","current":-6.096844,"twenty":-45.67687,"median":-13.432376,"eighty":-7.822188,"marketCap":114886078},{"date":"2024-08-02","current":-5.248314,"twenty":-45.438969,"median":-12.639572,"eighty":-6.797667,"marketCap":98896778},{"date":"2024-08-09","current":-6.741098,"twenty":-44.067543,"median":-12.367753,"eighty":-6.690814,"marketCap":127026102},{"date":"2024-08-16","current":-6.303607,"twenty":-42.052388,"median":-10.284417,"eighty":-6.64996,"marketCap":118143157},{"date":"2024-08-23","current":-8.29422,"twenty":-40.401079,"median":-9.899514,"eighty":-6.678244,"marketCap":155451523},{"date":"2024-08-30","current":-8.278421,"twenty":-39.141606,"median":-9.736016,"eighty":-6.690814,"marketCap":155155425},{"date":"2024-09-06","current":-8.136234,"twenty":-38.861724,"median":-9.674022,"eighty":-6.712813,"marketCap":152490542},{"date":"2024-09-13","current":-9.589698,"twenty":-36.881554,"median":-9.506677,"eighty":-6.734812,"marketCap":179731570},{"date":"2024-09-20","current":-12.386034,"twenty":-35.223248,"median":-9.49882,"eighty":-6.759954,"marketCap":232140941},{"date":"2024-09-27","current":-10.774586,"twenty":-34.271647,"median":-9.637093,"eighty":-6.791381,"marketCap":201938931},{"date":"2024-10-04","current":-8.578593,"twenty":-25.750182,"median":-9.548188,"eighty":-6.888805,"marketCap":160781290},{"date":"2024-10-11","current":-8.009846,"twenty":-20.168951,"median":-9.479108,"eighty":-7.001943,"marketCap":150121756},{"date":"2024-10-18","current":-7.425301,"twenty":-19.534707,"median":-9.44751,"eighty":-7.071981,"marketCap":139166125},{"date":"2024-10-25","current":-7.01454,"twenty":-19.059025,"median":-9.384317,"eighty":-6.903527,"marketCap":131467574},{"date":"2024-11-01","current":-6.714368,"twenty":-18.728312,"median":-9.226332,"eighty":-6.834437,"marketCap":125841709},{"date":"2024-11-08","current":-6.666973,"twenty":-18.282076,"median":-8.941959,"eighty":-6.759954,"marketCap":124953415},{"date":"2024-11-15","current":-4.809979,"twenty":-18.039704,"median":-8.846709,"eighty":-6.708049,"marketCap":110444606},{"date":"2024-11-22","current":-5.467643,"twenty":-17.654627,"median":-8.799568,"eighty":-6.673736,"marketCap":125545611},{"date":"2024-11-29","current":-5.132363,"twenty":-17.074838,"median":-8.768141,"eighty":-6.632216,"marketCap":117847059},{"date":"2024-12-06","current":-8.407791,"twenty":-16.522185,"median":-8.642433,"eighty":-6.569924,"marketCap":193055987},{"date":"2024-12-13","current":-6.737953,"twenty":-16.313655,"median":-8.594391,"eighty":-6.600602,"marketCap":154713889},{"date":"2024-12-20","current":-6.712037,"twenty":-15.964821,"median":-8.461728,"eighty":-6.495967,"marketCap":154118835},{"date":"2024-12-27","current":-6.310352,"twenty":-15.760957,"median":-8.366804,"eighty":-6.403683,"marketCap":144895507},{"date":"2025-01-03","current":-5.856836,"twenty":-15.652229,"median":-8.303377,"eighty":-6.363974,"marketCap":134482072},{"date":"2025-01-10","current":-5.325574,"twenty":-15.570683,"median":-8.28632,"eighty":-6.315537,"marketCap":122283477},{"date":"2025-01-17","current":-6.077115,"twenty":-15.523297,"median":-8.249595,"eighty":-6.288654,"marketCap":139540026},{"date":"2025-01-24","current":-6.517673,"twenty":-15.50282,"median":-8.139601,"eighty":-6.28436,"marketCap":149655935},{"date":"2025-01-31","current":-6.297394,"twenty":-15.473282,"median":-8.073041,"eighty":-6.236001,"marketCap":144597981},{"date":"2025-02-07","current":-7.867,"twenty":-15.425578,"median":-8.088839,"eighty":-6.236001,"marketCap":130062872},{"date":"2025-02-14","current":-7.722981,"twenty":-15.280653,"median":-8.030693,"eighty":-6.247693,"marketCap":127681858},{"date":"2025-02-21","current":-7.038894,"twenty":-15.117652,"median":-7.97035,"eighty":-6.260979,"marketCap":116372043},{"date":"2025-02-28","current":-7.200915,"twenty":-14.922849,"median":-7.899257,"eighty":-6.280067,"marketCap":119050684},{"date":"2025-03-07","current":-7.830995,"twenty":-14.578546,"median":-7.867,"eighty":-6.294726,"marketCap":129467618},{"date":"2025-03-14","current":-8.245048,"twenty":-14.152696,"median":-7.888185,"eighty":-6.298884,"marketCap":136313033},{"date":"2025-03-21","current":-8.209043,"twenty":-13.908059,"median":-7.867,"eighty":-6.302115,"marketCap":135717779},{"date":"2025-03-28","current":-7.110904,"twenty":-13.595467,"median":-7.836063,"eighty":-6.306305,"marketCap":117562550},{"date":"2025-04-04","current":-5.27467,"twenty":-13.332709,"median":-7.821994,"eighty":-6.280067,"marketCap":87204626},{"date":"2025-04-11","current":-4.842615,"twenty":-12.988406,"median":-7.793903,"eighty":-6.226574,"marketCap":80061584},{"date":"2025-04-17","current":-4.464567,"twenty":-12.673549,"median":-7.741272,"eighty":-6.154861,"marketCap":73811424},{"date":"2025-04-25","current":-4.590583,"twenty":-12.555761,"median":-7.674628,"eighty":-6.056383,"marketCap":75894811},{"date":"2025-05-02","current":-4.662592,"twenty":-12.434833,"median":-7.63297,"eighty":-6.012327,"marketCap":77085317},{"date":"2025-05-09","current":-4.48257,"twenty":-12.382378,"median":-7.614926,"eighty":-5.935607,"marketCap":74109050},{"date":"2025-05-16","current":-5.972632,"twenty":-12.227313,"median":-7.558201,"eighty":-5.893196,"marketCap":74406677},{"date":"2025-05-23","current":-5.255916,"twenty":-11.632708,"median":-7.513523,"eighty":-5.862019,"marketCap":65477876},{"date":"2025-05-30","current":-5.017011,"twenty":-11.501318,"median":-7.475136,"eighty":-5.83092,"marketCap":62501609},{"date":"2025-06-06","current":-4.801996,"twenty":-11.15375,"median":-7.4411,"eighty":-5.738446,"marketCap":59822968}],"updateTime":1749459396214}}}